HOME >> BIOLOGY >> NEWS
Food expert says more tests needed before fried foods are tabled

WEST LAFAYETTE, Ind. -- A Purdue University foods and nutrition associate professor is one of the nation's experts invited to Chicago at the end of the month to discuss the discovery of a potential carcinogen in starchy, fried foods.

"An ad hoc group, composed of food industry, trade association, and academic and government representatives, is bringing together food and nutrition experts to assess where we are on this topic and to plot the course for future action," said Charles Santerre, who specializes in chemical contaminants in food.

The workshop, Monday through Wednesday (10/28-10/30), is part of the annual National Center for Food Safety and Technology Conference that is sponsored by the Food and Drug Administration.

Six months ago the Swedish Food Authority reported that some of our favorite foods, such as potato chips and french fries, may contain acrylamide. At high levels, acrylamide has been shown to cause cancer in animals. The implications of the Swedish findings motivated the World Health Organization to rapidly convene international experts to discuss the impact of this discovery.

"The Food and Drug Administration is taking this very seriously, but there are holes in the data that can't be answered overnight," said Santerre, who began studying this topic more closely this spring and is well known for his research on contaminants in food. "We do know that we have been eating fried and baked foods for hundreds of years with no apparent adverse effects."

In April the Swedish Food Authority reported a wide range of acrylamide concentrations when examining a small number of starchy and fried foods. The amounts ranged from 30 to 2,300 parts per billion. Acrylamide is considered to be a probable human carcinogen and is a known neurotoxicant, said Joanne Lasrado, doctoral candidate in foods and nutrition at Purdue. The substance is a white crystalline, water-soluble compound that is used in the paper, paint, leather ta
'"/>

Contact: Amy Patterson-Neubert
apatterson@purdue.edu
765-494-9723
Purdue University
24-Oct-2002


Page: 1 2 3

Related biology news :

1. AAAS expert panel calls for voter-system research and reform
2. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
3. National nanotech expert to address UW-Madison conference
4. Leading experts in field of gene therapy to meet in Minneapolis
5. UC San Diego bioinformatics experts help reconstruct the genomic makeup of our ancestors
6. Veterinarians, wildlife experts applaud Chinas ban of wild bird trade
7. Risk and food are on the same plate: World food safety experts offer new methods to assess risk
8. Avian flu: Shut down wild bird markets, experts say
9. Gulf between rich, poor will grow if high-profile nanotechnology opponents prevail: ethics experts
10. Controversial UK badger killings analyzed by UC Davis expert
11. Physician experts available to speak on California fires and smoke inhalation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Food expert says more tests needed before fried foods are tabled

(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/19/2015)... 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host Laura ... to pay, and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
(Date:3/30/2015)... PMG Research, Benchmark Research, and ... formation of VaxCorps, a network of highly experienced, ... conduct of vaccine trials in healthy adult, elderly, ... successfully conducted over 500 phase I-III vaccine clinical ... influenza as well as a vast array of ...
(Date:3/30/2015)... IRVINE, Calif. , March 30, 2015 /PRNewswire/ ... that its subsidiary corporation, NuGene BioPharma, Inc. has ... board. Dr. Guan is an internationally ... After finishing his college education at Peking University, ... his Ph.D. degree from the University of North ...
(Date:3/30/2015)... ROCKVILLE, Md. , March 30, 2015 ... company dedicated to the acquisition, development and commercialization of ... for the global market with a commercial focus on ... China Food and Drug Administration (CFDA) has approved the ... trial in ovarian clear cell carcinoma (OCCC) patients for ...
(Date:3/30/2015)... 30, 2015  Spherix Incorporated (Nasdaq: SPEX ... fostering and monetization of intellectual property, today provided ... 3:13-cv-03494-M and  Spherix v. Uniden , Case No. ... for the Northern District of Texas ... v. Verizon, Case No. 1:14-cv-00721-GBL-TCB, in the ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
Cached News: